Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/once-or-twice-yearly-injection-weight-loss-2026a10009n4?src=rss
Author :
Publish date : 2026-03-30 12:54:00
Copyright for syndicated content belongs to the linked Source.
